Abstract Number: 994 • 2016 ACR/ARHP Annual Meeting
Validation Studies of the American College of Rheumatology (ACR) 2010 Fibromyalgia Diagnostic Criteria and the 2011 Self-Report Modification for Survey and Clinical Research
Background/Purpose: The provisional criteria of the American College of Rheumatology (ACR) 2010 and the 2011 self-report modification for survey and clinical research are widely used…Abstract Number: 995 • 2016 ACR/ARHP Annual Meeting
Use of Opiate Diminished the Treatment Benefits of Motivational Interviewing for Fibromyalgia
Background/Purpose: Opiate is not indicated in the treatment of fibromyalgia (FM). In fact, chronic use of opiate may even worsen the symptoms of fibromyalgia. There…Abstract Number: 996 • 2016 ACR/ARHP Annual Meeting
Use of a Shared Medical Appointment for Patients with Fibromyalgia in a Rural, Academic Medical Center: A Process Improvement Initiative for the Development of a New Care Model
Background/Purpose: Fibromyalgia is a complex chronic pain condition with patients often presenting with multiple somatic complaints that are difficult to address in standard new patient…Abstract Number: 997 • 2016 ACR/ARHP Annual Meeting
2016 Revisions to the 2010/2011 Fibromyalgia Diagnostic Criteria
Background/Purpose: The provisional criteria of the ACR 2010 and the 2011 self-report modification for survey and clinical research are valid, reliable and widely used for…Abstract Number: 998 • 2016 ACR/ARHP Annual Meeting
Brain Responses to Other’s Pain in Fibromyalgia – a Magnetoencephalography (MEG) Study
Background/Purpose: Fibromyalgia Syndrome (FMS) is a disorder characterized by the presence of widespread pain and tenderness, which is now believed to be, at least in…Abstract Number: 999 • 2016 ACR/ARHP Annual Meeting
Utility of Neutrophil CD64 Expression & sTREM-1 in Distinguishing Bacterial Infection from Disease Flare in SLE and ANCA Associated Vasculitis
Background/Purpose: Fever is a common presenting manifestation of systemic lupus erythematosus (SLE) and ANCA associated vasculitis (AAV). Treating physician is challenged to differentiate between disease…Abstract Number: 1000 • 2016 ACR/ARHP Annual Meeting
Subclinical Cytomegalovirus Viremia Is Associated with Increased Nosocomial Infections and Prolonged Hospitalization in Patients with Systemic Autoimmune Diseases
Background/Purpose: Both subclinical cytomegalovirus (CMV) viremia and CMV disease have been associated with adverse outcomes in select immunosuppressed populations, including an increased incidence of other…Abstract Number: 1001 • 2016 ACR/ARHP Annual Meeting
Cytomegalovirus Reactivation in Connective Tissue Disease By Immunosuppressive Therapy Predicts Severe Infection and High Mortality
Background/Purpose: Intensive immunosuppressive treatment for remission induction in connective tissue diseases (CTDs) sometimes causes serious infection. Cytomegalovirus (CMV) is a herpesvirus remaining latent after primary…Abstract Number: 1002 • 2016 ACR/ARHP Annual Meeting
Pneumocystis Jiroveci in Rheumatic Disease: A 20 Year Single-Center Experience
Background/Purpose: Pneumocystis jiroveci (PJP) is an opportunistic infection associated with high mortality in patients with rheumatologic conditions. Given the paucity of data, clinical guidelines to…Abstract Number: 1003 • 2016 ACR/ARHP Annual Meeting
Ultrasonography Changes during the Course of Septic Arthritis ARE Associated with Functional Outcome
Background/Purpose: The main goal of this study was to describe the US changes observed during the course of septic arthritis and their association with…Abstract Number: 1004 • 2016 ACR/ARHP Annual Meeting
Herpes Zoster Virus Infection in Patients Treated with Biological Therapies (BIOBADASAR)
Background/Purpose: Biologic therapies (bDMARDs) have improved the treatment of rheumatic diseases; however, the risk of herpes zoster (HZ) virus infection or reactivation in patients treated…Abstract Number: 1005 • 2016 ACR/ARHP Annual Meeting
Biallelic Hypomorphic Mutations in a Linear Deubiquitinase Define Otulipenia, an Early-Onset Systemic Autoinflammatory Disease
Background/Purpose: Autoinflammatory diseases are caused by mutations in genes regulating innate immune responses. More than 20 genes have been associated with various monogenic autoinflammatory disorders.…Abstract Number: 1006 • 2016 ACR/ARHP Annual Meeting
Immune Complex-Mediated TLR8 Activation Shifts Neutrophils from Phagocytosis to Netosis through Furin-Dependent Shedding of Fcgriia
Background/Purpose: Neutrophils, isolated from healthy individuals, were incubated with RNA-ICs and analyzed for phagocytosis and NETosis by flow cytometry and fluorimetry, respectively, in the presence…Abstract Number: 1007 • 2016 ACR/ARHP Annual Meeting
Interferon Regulatory Factor 1 Is the Key Driver of Inflammasome Activity in Systemic Lupus Erythematosus
Background/Purpose: The inflammasome complex has recently emerged as a driver of organ damage in systemic lupus erythematosus (SLE). This complex, via its enzymatic subunit caspase-1,…Abstract Number: 1008 • 2016 ACR/ARHP Annual Meeting
Advantageous Effect of an Endogenous Retroviral Envelope Protein in Systemic Lupus Erythematosus with Ex Vivo and In Vivo Anti-Inflammatory Potential
Background/Purpose: Human Endogenous Retroviruses (HERVs) are remnants of retroviral infections in the human germline. Most, but not all, HERV genes have become inactive by accumulation…
ACR Meeting Abstracts